Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Macrophage / Inflamm.

Recombinant Chicken MIF protein (ab88204)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Cow CCL4/MIP-1 beta protein (ab87504)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Cow CCL4/MIP-1 beta protein (ab128558)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Cow IL-1 alpha protein (ab87390)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Cow Macrophage Inflammatory Protein 1 alpha / CCL3 (ab209284)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Dog CCL4/MIP-1 beta protein (ab209117)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Dog CX3CL1 protein (ab208808)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Dog IL-1 alpha protein (ab169717)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Human CCL4/MIP-1 beta protein (Fc Chimera) (ab216244)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

Recombinant Human CX3CL1 protein (Fc Chimera) (ab215010)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:
  • ‹
  • 1
  • 2
  • ...
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • ...
  • 223
  • 224
  • ›
Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.